A. ÖWALL

Publication List Details

Period

1995 - 2005

Number

5

Co-Authors

Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery? (2005)

Anderson, R.E., Klerdal, K., Ivert, T., Hammar, N., Barr, G., Öwall, A.

Aims Impaired fasting glucose (IFG) below the diagnostic threshold for diabetes mellitus (DM) is associated with macrovascular pathology and increased mortality after percutaneous coronary...

Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery? (2005)

Anderson, R.E., Klerdal, K., Ivert, T., Hammar, N., Barr, G., Öwall, A.

Aims Impaired fasting glucose (IFG) below the diagnostic threshold for diabetes mellitus (DM) is associated with macrovascular pathology and increased mortality after percutaneous coronary...

Fentanyl and midazolam anaesthesia for coronary bypass surgery: a clinical study of bispectral electroencephalogram analysis, drug concentrations and recall (2000)

Barr, G., Anderson, R. E., Samuelsson, S., Öwall, A., Jakobsson, J. G.

Bispectral index (BIS) was assessed as a monitor of depth of anaesthesia during fentanyl and midazolam anaesthesia for coronary bypass surgery. In 10 patients given morphine premedication,...

Cardiac oufflow of endothelin, neuropeptide Y and noradrenaline in relation to hyperaemia in coronary sinus flow following electrical conversion of induced ventricular fibrillation in man (1995)

RUNSIÖ, M., ROSENQVIST, M., BERGFELDT, L., ÖWALL, A., LUNDBERG, J. M., FRANCO-CERECEDA, A.

The implanted cardioverter defibrillator represents an alternative therapy for patients with drug-refractory nialignant ventricular arrhythmios. Implantation and testing of the device requires that...

Cardiac oufflow of endothelin, neuropeptide Y and noradrenaline in relation to hyperaemia in coronary sinus flow following electrical conversion of induced ventricular fibrillation in man (1995)

RUNSIÖ, M., ROSENQVIST, M., BERGFELDT, L., ÖWALL, A., LUNDBERG, J. M., FRANCO-CERECEDA, A.

The implanted cardioverter defibrillator represents an alternative therapy for patients with drug-refractory nialignant ventricular arrhythmios. Implantation and testing of the device requires that...